Vancomycin-induced Immune Hemolytic Anemia – A case report and literature review

Drug-induced immune hemolytic anemia (DIIHA) is a rare complication of drug treatment. The clinical presentation involves rapid dropping of hemoglobin secondary to hemolysis leading to potentially fatal consequences. Over 100 drugs have been reported to cause DIIHA, most commonly cephalosporins. Here, we present a case of vancomycin-induced immune hemolytic anemia. The diagnosis was challenging due to the limited reports of hemolytic anemia induced by vancomycin in the setting of multiple antibiotic administration history. Hemolysis improved after vancomycin cessation and diagnosis was made with positive serological confirmation. Literature review was performed with four reported cases of vancomycin-induced immune hemolytic anemia identified and summarized. Our goal is to promote awareness of vancomycin as an uncommon cause of DIIHA for better management in clinical practice.

Authors

Institutions

Publication Details

Journal
Journal of Community Hospital Internal Medicine Perspectives
Published
2025-09-12
DOI
https://doi.org/10.55729/2000-9666.1539
Primary Topic
Blood groups and transfusion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vancomycin-induced Immune Hemolytic Anemia – A case report and literature review

Meher Ali, Harsh Patel, Rashid Shaikh, Yilin Song et al.
Journal of Community Hospital Internal Medicine Perspectives
Blood groups and transfusion
article

Vancomycin-induced Immune Hemolytic Anemia – A case report and literature review

Meher Ali, Harsh Patel, Rashid Shaikh, Yilin Song, Ashley Bersma
article en

Abstract

Drug-induced immune hemolytic anemia (DIIHA) is a rare complication of drug treatment. The clinical presentation involves rapid dropping of hemoglobin secondary to hemolysis leading to potentially fatal consequences. Over 100 drugs have been reported to cause DIIHA, most commonly cephalosporins. Here, we present a case of vancomycin-induced immune hemolytic anemia. The diagnosis was challenging due to the limited reports of hemolytic anemia induced by vancomycin in the setting of multiple antibiotic administration history. Hemolysis improved after vancomycin cessation and diagnosis was made with positive serological confirmation. Literature review was performed with four reported cases of vancomycin-induced immune hemolytic anemia identified and summarized. Our goal is to promote awareness of vancomycin as an uncommon cause of DIIHA for better management in clinical practice.

Journal of Community Hospital Internal Medicine PerspectivesVol. 15(5)
University of Maryland, Baltimore (US), Mayo Clinic (US), Mayo Clinic in Arizona (US), University of Maryland Medical Center Midtown Campus (US), Mayo Clinic in Florida (US), American University of Antigua (AG)
Openalex Percentile: Top 68%
Blood groups and transfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Vancomycin-induced Immune Hemolytic Anemia – A case report and literature review — Meher Ali, Harsh Patel, et al. · Journal of Community Hospital Internal Medicine Perspectives (2025) | TGRS Research Map | TGRS